The TAG Team Is
Here to Help!
We work closely with our prospective clients to determine the best level of support based on
goals and current perceived gaps.
Whether it’s a phone consultation, online training or onsite visits – we’re here to help you!
​
​
800.401.2239
Key Points
Updated: June 16, 2020
​
-
The CDC has posted new guidance on COVID-19 testing strategies. For a summary of its impacts, check out today’s Recommendations for Industry.
-
All CDC Communication Resources (from guidance documents to videos, to images, to public service announcements, to resources for limited-English-proficient populations) can be found, here.
-
In other COVID-19 news, for safety, some airlines have suspended “all or part of their alcoholic drinks service in response to COVID-19” to minimize crew and passenger interactions.
-
The FDA has revoked emergency use authorization for chloroquine and hydroxychloroquine. [FDA News Release link].
-
Additionally, the FDA does not recommend the co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate. Co-administrating remdesivir with either latter compounds can reduce the antiviral activity of remdesivir. Read more, here.
-
-
There have now been over 8 million cases of COVID-19 throughout the world.
Recommendations for Industry
You Have a Confirmed COVID-19 Case: What Should You Do?
​
CDC has posted new guidance on COVID-19 testing strategies in critical infrastructure workplaces for when a positive case is confirmed. The guidance provides a three-tiered system for prioritizing worker testing. It starts with close contacts who were most likely to be exposed (Tier 1); then moves to same-shift/different-area workers who may have been exposed (Tier 2); then finally to other same-shift or back-to-back shift workers who may have been exposed in common areas, etc. (Tier 3).
Additionally, the CDC:
-
Reaffirms the potential of asymptomatic person to transmit the virus. The CDC states: “Early experience from COVID-19 outbreaks in a variety of settings suggests that when symptomatic workers with COVID-19 are identified, there are often asymptomatic or pre-symptomatic workers with SARS-CoV-2 present at the workplace.”
-
Breaks down the testing and return-to-work recommendations for each of the three tiers in a flowchart [link here].
-
States that “a testing strategy should only be implemented if results will lead to specific actions.” Their statement tracks withTAG’s recommendations on implementing testing only if you know what you will do with the results.
With all this, it is still complex to determine the best business strategy and testing decisions for the occurrence of a positive COVID-19 case in your facility. Businesses can continue to reduce risk through the continued implementation of all pandemic protective controls (wellness checks, six-foot distancing, employee hygiene, enhanced cleaning and sanitation, and masks).
If you have not yet developed a strategy for handling the occurrence of positive case(s), or if you want to incorporate testing into your plan, reach out to TAG. We can help.
Outbreak Updates
As of June 16, 2020 (11:01 ET), there are over 8,065,000 cases (>437,000 deaths) worldwide.
​
Due to the increasing number of cases in the United States, TAG will move from reporting counts per country to focus on the United States, please see here for the data. For further information regarding worldwide numbers, please refer to John Hopkin University’s aggregate map.
Keep up to date with COVID-19:
​
Please send us any questions, comments, and/or concerns! We are happy to talk with you.
OR call us at 1-800-401-2239
Get the Insights & Guidance You Need!
Learn how TAG can help your company ensure food safety and brand protection.
Contact us today!